Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IXABEPILONE vs JAKAFI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IXABEPILONE vs JAKAFI: Safety Overview

Metric IXABEPILONE JAKAFI
Total FAERS Reports 368 1,749
Deaths Reported 104 152
Death Rate 28.3% 8.7%
Hospitalizations 98 214
Average Patient Age 58.6 yrs 70.6 yrs
% Female Patients 93.5% N/A
FDA Approval Date Oct 16, 2007 N/A
Manufacturer R-Pharm US Operating, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A